A previous study reported that HOXB13 promoted ovarian cancer proliferation and conferred resistance to tamoxifen-mediated apoptosis [25], but the molecular mechanism of HOXB13-mediated tumor progression remains obscure. This evidence concerns the gene HOXB13 and ovarian carcinoma.